Pulmonary disease associated with Pseudomonas aeruginosa in cystic fibrosis: current status of the host-bacterium interaction.
D000268:Adhesiveness; D000818:Animals; D000907:Antibodies, Bacterial / Q000096:biosynthesis / Q000276:immunology; D000936:Antigen-Antibody Complex / Q000276:immunology; D003165:Complement System Proteins / Q000276:immunology; D003550:Cystic Fibrosis / Q000150:complications* / Q000276:immunology / Q000382:microbiology; D006801:Humans; D008168:Lung / Q000382:microbiology*; D008264:Macrophages / Q000276:immunology; D009093:Mucus / Q000378:metabolism; D009504:Neutrophils / Q000201:enzymology; D010196:Pancreatic Elastase / Q000276:immunology; D010447:Peptide Hydrolases / Q000097:blood; D010587:Phagocytosis; D011135:Polysaccharides, Bacterial / Q000276:immunology; D011552:Pseudomonas Infections / Q000209:etiology* / Q000276:immunology / Q000382:microbiology; D011550:Pseudomonas aeruginosa / Q000201:enzymology / Q000254:growth & development / Q000276:immunology / Q000502:physiology*
D000907:Antibodies, Bacterial; D000936:Antigen-Antibody Complex; D011135:Polysaccharides, Bacterial; D003165:Complement System Proteins; D010447:Peptide Hydrolases; D010196:Pancreatic Elastase